Detection of protein on BTLAlow cells and in vivo antibody-mediated down-modulation of BTLA on lymphoid and myeloid cells of C57BL/6 and BALB/c BTLA allelic variants

Immunobiology

Volumn 215, Issue 7, 2010, Pages 570-578

  del Rio, Maria Luisa ^a   Kaye, Jonathan ^b   Rodriguez Barbosa, Jose Ignacio ^a  

^a UNIVERSITY OF LEÓN   (Spain)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

BTLA; Co inhibition; Co stimulation; HVEM; Receptor down modulation

Indexed keywords

B AND T LYMPHOCYTE ATTENUATOR; MEMBRANE PROTEIN; UNCLASSIFIED DRUG; BTLA PROTEIN, MOUSE; EPITOPE; HERPESVIRUS ENTRY MEDIATOR; HYBRID PROTEIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN RECEPTOR; LEUKOCYTE ANTIGEN; MONOCLONAL ANTIBODY; TNFRSF14 PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; BAGG ALBINO MOUSE; BONE MARROW CELL; C57BL 6 MOUSE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETIC VARIABILITY; IMMUNOMODULATION; INTERNALIZATION; LYMPHOID CELL; MOUSE; NATURAL KILLER CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION; ALLELE; ANIMAL; ANTIGEN ANTIBODY REACTION; BIOSYNTHESIS; C57BL MOUSE; GENETICS; IMMUNOLOGY; LEWIS RAT; LYMPHOCYTE; METABOLISM; MOLECULAR CLONING; PATHOLOGY; TRANSGENE;

ALLELES; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGEN-ANTIBODY REACTIONS; ANTIGENS, CD; CLONING, MOLECULAR; EPITOPES; FEMALE; IMMUNOGLOBULIN G; LYMPHOCYTES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MYELOID CELLS; RATS; RATS, INBRED LEW; RECEPTORS, IMMUNOLOGIC; RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 14; RECOMBINANT FUSION PROTEINS; TRANSGENES;

EID: 77953540378     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imbio.2009.09.008     Document Type: Article

References (42)

1. Adams A.B., Larsen C.P., Pearson T.C., Newell K.A. The role of TNF receptor and TNF superfamily molecules in organ transplantation. Am. J. Transplant. 2002, 2:12-18.
2. Cai G., Freeman G.J. The CD160, BTLA, LIGHT/HVEM pathway: a bidirectional switch regulating T-cell activation. Immunol. Rev. 2009, 229:244-258.
3. Carreno B.M., Collins M. The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses. Annu. Rev. Immunol 2002, 20:29-53.
4. Carreno B.M., Collins M. BTLA: a new inhibitory receptor with a B7-like ligand. Trends Immunol 2003, 24:524-527.
5. Chemnitz J.M., Lanfranco A.R., Braunstein I., Riley J.L. B and T lymphocyte attenuator-mediated signal transduction provides a potent inhibitory signal to primary human CD4 T cells that can be initiated by multiple phosphotyrosine motifs. J. Immunol. 2006, 176:6603-6614.
6. Darby C.R., Hamano K., Wood K.J. Purification of monoclonal antibodies from tissue culture medium depleted of IgG. J. Immunol. Methods 1993, 159:125-129.
7. Del Rio M.L., Buhler L., Gibbons C., Tian J., Rodriguez-Barbosa J.I. PD-1/PD-L1, PD-1/PD-L2, and other co-inhibitory signaling pathways in transplantation. Transpl. Int. 2008, 21:1015-1028.
8. Del Rio M.L., Penuelas-Rivas G., Dominguez-Perles R., Ramirez P., Parrilla P., Rodriguez-Barbosa J.I. Antibody-mediated signaling through PD-1 costimulates T cells and enhances CD28-dependent proliferation. Eur. J. Immunol. 2005, 35:3545-3560.
9. Del Rio M.L., Rodriguez-Barbosa J.I., Kremmer E., Forster R. CD103- and CD103+ bronchial lymph node dendritic cells are specialized in presenting and cross-presenting innocuous antigen to CD4+ and CD8+ T cells. J. Immunol 2007, 178:6861-6866.
10. Deppong C., Degnan J.M., Murphy T.L., Murphy K.M., Green J.M. B and T lymphocyte attenuator regulates T cell survival in the lung. J. Immunol. 2008, 181:2973-2979.
11. Deppong C., Juehne T.I., Hurchla M., Friend L.D., Shah D.D., Rose C.M., Bricker T.L., Shornick L.P., Crouch E.C., Murphy T.L., Holtzman M.J., Murphy K.M., Green J.M. Cutting edge: B and T lymphocyte attenuator and programmed death receptor-1 inhibitory receptors are required for termination of acute allergic airway inflammation. J. Immunol. 2006, 176:3909-3913.
12. Gao X., Huang L. Cationic liposome-mediated gene transfer. Gene Ther 1995, 2:710-722.
13. Han P., Goularte O.D., Rufner K., Wilkinson B., Kaye J. An inhibitory Ig superfamily protein expressed by lymphocytes and APCs is also an early marker of thymocyte positive selection. J. Immunol 2004, 172:5931-5939.
14. Hurchla M.A., Sedy J.R., Gavrieli M., Drake C.G., Murphy T.L., Murphy K.M. B and T lymphocyte attenuator exhibits structural and expression polymorphisms and is highly Induced in anergic CD4+ T cells. J. Immunol. 2005, 174:3377-3385.
15. Hurchla M.A., Sedy J.R., Murphy K.M. Unexpected role of B and T lymphocyte attenuator in sustaining cell survival during chronic allostimulation. J. Immunol 2007, 178:6073-6082.
16. Krieg C., Boyman O., Fu Y.X., Kaye J. B and T lymphocyte attenuator regulates CD8+ T cell-intrinsic homeostasis and memory cell generation. Nat. Immunol 2007, 8:162-171.
17. Krieg C., Han P., Stone R., Goularte O.D., Kaye J. Functional analysis of B and T lymphocyte attenuator engagement on CD4+ and CD8+ T cells. J. Immunol. 2005, 175:6420-6427.
18. Lanier L.L. NK cell recognition. Annu. Rev. Immunol. 2005, 23:225-274.
19. Leibson P.J. The regulation of lymphocyte activation by inhibitory receptors. Curr. Opin. Immunol. 2004, 16:328-336.
20. Lenschow D.J., Walunas T.L., Bluestone J.A. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 1996, 14:233-258.
21. Lepenies B., Pfeffer K., Hurchla M.A., Murphy T.L., Murphy K.M., Oetzel J., Fleischer B., Jacobs T. Ligation of B and T lymphocyte attenuator prevents the genesis of experimental cerebral malaria. J. Immunol. 2007, 179:4093-4100.
22. Miller J.F., Morahan G. Peripheral T cell tolerance. Annu. Rev. Immunol. 1992, 10:51-69.
23. Miller, M.L., Sun, Y., Fu, Y.X. 2009. Cutting edge: B and T lymphocyte attenuator signalingon NKT cells inhibits cytokine release and tissue injuryin early immune responses. J. Immunol.
24. Murphy K.M., Nelson C.A., Sedy J.R. Balancing co-stimulation and inhibition with BTLA and HVEM. Nat. Rev. Immunol. 2006, 6:671-681.
25. Nishimura H., Okazaki T., Tanaka Y., Nakatani K., Hara M., Matsumori A., Sasayama S., Mizoguchi A., Hiai H., Minato N., Honjo T. Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science 2001, 291:319-322.
26. Oosterwegel M.A., Greenwald R.J., Mandelbrot D.A., Lorsbach R.B., Sharpe A.H. CTLA-4 and T cell activation. Curr. Opin. Immunol. 1999, 11:294-300.
27. Ravetch J.V., Lanier L.L. Immune inhibitory receptors. Science 2000, 290:84-89.
28. Riley J.L., June C.H. The CD28 family: a T-cell rheostat for therapeutic control of T-cell activation. Blood 2005, 105:13-21.
29. Rodriguez-Barbosa J.I., Gutierrez Martin C.B., Tascon R.I., Suarez J., Rodriguez Ferri E.F. Evidence obtained with monoclonal antibodies that O antigen is the major antigen responsible for the cross-reactivities between serotypes 4 and 7 of Actinobacillus (Haemophilus) pleuropneumoniae. Clin. Diagn. Lab Immunol 1995, 2:563-568.
30. Schwartz R.H. T cell anergy. Annu. Rev. Immunol. 2003, 21:305-334.
31. Schwartz R.H. A cell culture model for T lymphocyte clonal anergy. Science 1990, 248:1349-1356.
32. Sedy J.R., Gavrieli M., Potter K.G., Hurchla M.A., Lindsley R.C., Hildner K., Scheu S., Pfeffer K., Ware C.F., Murphy T.L., Murphy K.M. B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator. Nat. Immunol. 2005, 6:90-98.
33. Tao R., Wang L., Han R., Wang T., Ye Q., Honjo T., Murphy T.L., Murphy K.M., Hancock W.W. Differential effects of B and T lymphocyte attenuator and programmed death-1 on acceptance of partially versus fully MHC-mismatched cardiac allografts. J. Immunol. 2005, 175:5774-5782.
34. Truong W., Plester J.C., Hancock W.W., Kaye J., Merani S., Murphy K.M., Murphy T.L., Anderson C.C., Shapiro A.M. Negative and positive co-signaling with anti-BTLA (PJ196) and CTLA4Ig prolongs islet allograft survival. Transplantation 2007, 84:1368-1372.
35. Truong W., Plester J.C., Hancock W.W., Merani S., Murphy T.L., Murphy K.M., Kaye J., Anderson C.C., Shapiro A.M. Combined coinhibitory and costimulatory modulation with anti-BTLA and CTLA4Ig facilitates tolerance in murine islet allografts. Am. J. Transplant. 2007, 7:2663-2674.
36. Unkeless J.C. Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors. J. Exp. Med 1979, 150:580-596.
37. Vendel A.C., Calemine-Fenaux J., Izrael-Tomasevic A., Chauhan V., Arnott D., Eaton D.L. B and T lymphocyte attenuator regulates B Cell receptor signaling by targeting Syk and BLNK. J. Immunol. 2009, 182:1509-1517.
38. Walunas T.L., Lenschow D.J., Bakker C.Y., Linsley P.S., Freeman G.J., Green J.M., Thompson C.B., Bluestone J.A. CTLA-4 can function as a negative regulator of T cell activation. Immunity 1994, 1:405-413.
39. Ware C.F. Targeting lymphocyte activation through the lymphotoxin and LIGHT pathways. Immunol. Rev 2008, 223:186-201.
40. Watanabe N., Gavrieli M., Sedy J.R., Yang J., Fallarino F., Loftin S.K., Hurchla M.A., Zimmerman N., Sim J., Zang X., Murphy T.L., Russell J.H., Allison J.P., Murphy K.M. BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1. Nat. Immunol. 2003, 4:670-679.
41. Zeng C., Wu T., Zhen Y., Xia X.P., Zhao Y. BTLA, a new inhibitory B7 family receptor with a TNFR family ligand. Cell Mol. Immunol. 2005, 2:427-432.
42. Zeng C., Zhen Y., Shu S.A., Wu T., Yi H., Lian Z.X., Zhao Y. The influence of cyclosporin A on lymphocyte attenuator expression. J. Autoimmun. 2007, 28:234-244.